Background: Low molecular weight heparins, which are the reference anticoagulants used in pregnancy for many years due to their advantages such as easy use and long plasma half-life in recent years, are considered safe for the fetus since they do not cross the placenta. However, since some expectant mothers have difficulty in adapting to these treatment methods, which are mandatory during pregnancy, this situation leads pregnant women to worry and pessimism during the learning phase of injection. It is emphasized that this anxiety experienced during pregnancy is a global health problem due to its negative consequences on mother and baby.
Objective: The study was planned to determine the concerns about the health of the baby, the fear of losing the baby, and the ability to administer injections in pregnant women who applied subcutaneous injection.
Materyal and Method: Data were collected using the "Participant Introduction Form", "Subcutaneous Injection Administration Skills Evaluation Form", and the Diagnosis Form for Worry and Fear of Loss in Pregnant Women. Pregnant women who met the inclusion and exclusion criteria between 01.07.2022 and 31.10.2022, followed up in the Family Health Center no.5 and applied subcutaneous injection were included in the study. The measurement tools were applied by the researchers by face-to-face interview method during the application of the pregnant women to the clinic.
Results: 37.3% of women have a chronic disease, and hypothyroidism (10%) and hypertension (7.3%) are common. The mean duration of subcutaneous injection of the women was 2.71±0.99, it was determined that they injected the most because of the low threat (71.8%), the majority of them received training on injection (82.7%) and they received this training from health professionals (71.8%). It was observed that women made the most mistakes in the subcutaneous administration phase, during the delivery of the drug into the tissue. Considering the concerns of pregnant women about the health of the baby due to subcutaneous injection, 68.2% of pregnant women are feared that a problem will develop in their baby's organs and 95.5% are feared that they will lose their baby.
Conclusion: The fact that pregnant women take on the responsibility of administering subcutaneous injection becomes a secondary source of stress.It is important to teach, support, follow and answer the questions of subcutaneous administration correctly and completely to pregnant women.Identifying the most common problems in such applications allows the service to be improved.
Keyword: Subcutaneous administration, pregnant, high risk pregnant.